The estimated Net Worth of Kevin L Roberg is at least $459 Tysiąc dollars as of 15 August 2005. Kevin Roberg owns over 116,562 units of Omnicell stock worth over $459,298 and over the last 21 years Kevin sold OMCL stock worth over $0.
Kevin has made over 4 trades of the Omnicell stock since 2004, according to the Form 4 filled with the SEC. Most recently Kevin exercised 116,562 units of OMCL stock worth $589,804 on 15 August 2005.
The largest trade Kevin's ever made was exercising 116,562 units of Omnicell stock on 15 August 2005 worth over $589,804. On average, Kevin trades about 14,340 units every 63 days since 2003. As of 15 August 2005 Kevin still owns at least 10,664 units of Omnicell stock.
You can see the complete history of Kevin Roberg stock trades at the bottom of the page.
Kevin's mailing address filed with the SEC is , , , , .
Over the last 21 years, insiders at Omnicell have traded over $118,258,750 worth of Omnicell stock and bought 526,030 units worth $5,215,749 . The most active insiders traders include William H Jr Younger, Randall A Lipps oraz Benjamin A Horowitz. On average, Omnicell executives and independent directors trade stock every 10 days with the average trade being worth of $482,255. The most recent stock trade was executed by Christine Marie Mellon on 9 June 2023, trading 7,951 units of OMCL stock currently worth $581,536.
since 1992, omnicell has been creating new efficiencies to improve patient care, anywhere it is delivered. omnicell is a leading supplier of comprehensive automation and business analytics software for patient-centric medication and supply management across the entire health care continuum—from the acute care hospital setting to post-acute skilled nursing and long-term care facilities to the home. omnicell’s automated hardware/software systems for medication dispensing include solutions from the point of entry into the hospital through the central pharmacy, nursing unit, operating room, and patient bedside. our supply management systems promote greater cost control and charge capture for payer reimbursement, and improve management and reordering of inventory. omnicell® products range from high-security, closed-cabinet systems and software to open-shelf and combination systems in the nursing unit, cath lab, and operating room. more than 3,200 customers worldwide have utilized omnice
Omnicell executives and other stock owners filed with the SEC include: